Holen Sie sich die Stockscreener-App
8.12
4.93%
-0.40
Schlusskurs vom Vortag:
$8.52
Offen:
$8.48
24-Stunden-Volumen:
107.72K
Relative Volume:
0.19
Marktkapitalisierung:
$252.04M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-29.25M
KGV:
-6.8465
EPS:
-1.186
Netto-Cashflow:
$-22.80M
1W Leistung:
-5.81%
1M Leistung:
+11.11%
6M Leistung:
+111.49%
1J Leistung:
+51.97%
1-Tages-Spanne:
$8.10
$8.624
1-Wochen-Bereich:
$8.02
$8.66
52-Wochen-Spanne:
$1.73
$11.41
Sagimet Biosciences Inc Stock (SGMT) Company Profile
Firmenname
Sagimet Biosciences Inc
Sektor
Branche
Telefon
(650) 561-8600
Adresse
155 BOVET RD., SUITE 303, SAN MATEO
Vergleichen Sie SGMT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SGMT
Sagimet Biosciences Inc
|
8.13 | 277.08M | 0 | -29.25M | -22.80M | -1.186 |
|
VRTX
Vertex Pharmaceuticals Inc
|
419.89 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
633.01 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
433.75 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
813.92 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
179.34 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Sagimet Biosciences Inc Stock (SGMT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Eingeleitet | Wedbush | Outperform |
| 2025-08-07 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-07-24 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-12-06 | Eingeleitet | Oppenheimer | Outperform |
| 2024-11-12 | Eingeleitet | UBS | Buy |
| 2024-06-28 | Herabstufung | Goldman | Buy → Neutral |
| 2024-05-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-03-25 | Eingeleitet | Leerink Partners | Outperform |
| 2023-08-08 | Eingeleitet | Goldman | Buy |
| 2023-08-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-08-08 | Eingeleitet | Piper Sandler | Overweight |
| 2023-08-08 | Eingeleitet | TD Cowen | Outperform |
Alle ansehen
Sagimet Biosciences Inc Aktie (SGMT) Neueste Nachrichten
Will Sagimet Biosciences Inc. rebound enough to break even2025 Macro Impact & Weekly Momentum Stock Picks - newser.com
Is Sagimet Biosciences Inc. (0O2) stock worth holding before Fed meetingJuly 2025 Reactions & High Accuracy Investment Signals - newser.com
Chart based exit strategy for Sagimet Biosciences Inc.July 2025 Fed Impact & Verified Momentum Watchlists - newser.com
Is Sagimet Biosciences Inc. stock resilient to inflation2025 Market Overview & Growth Focused Investment Plans - newser.com
Sagimet Biosciences Inc. (NASDAQ:SGMT) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
How Sagimet Biosciences Inc. (0O2) stock trades after earnings2025 Bull vs Bear & Technical Pattern Based Buy Signals - newser.com
Quantitative breakdown of Sagimet Biosciences Inc. recent moveBuy Signal & Low Drawdown Trading Strategies - newser.com
Can Sagimet Biosciences Inc. (0O2) stock attract analyst upgrades2025 Earnings Impact & Low Volatility Stock Recommendations - newser.com
Key metrics from Sagimet Biosciences Inc.’s quarterly dataWeekly Gains Report & Reliable Intraday Trade Plans - newser.com
How Sagimet Biosciences Inc. stock benefits from global expansion2025 Stock Rankings & Precise Swing Trade Entry Alerts - newser.com
Identifying reversal signals in Sagimet Biosciences Inc.Analyst Downgrade & Long Hold Capital Preservation Tips - newser.com
Will Sagimet Biosciences Inc. stock deliver shareholder valueWeekly Stock Report & Community Consensus Stock Picks - newser.com
Sagimet Biosciences Inc. $SGMT Shares Sold by Dumac Inc. - MarketBeat
Why Sagimet Biosciences Inc. (0O2) stock is a strong analyst pickJuly 2025 Sector Moves & Risk Controlled Stock Alerts - newser.com
What does recent volatility data suggest for Sagimet Biosciences Inc.2025 Top Gainers & Smart Swing Trading Techniques - newser.com
Relative strength of Sagimet Biosciences Inc. in sector analysis2025 Breakouts & Breakdowns & Risk Managed Investment Strategies - newser.com
Published on: 2025-10-31 03:58:37 - newser.com
Regression analysis insights on Sagimet Biosciences Inc. performance2025 Top Decliners & Step-by-Step Swing Trade Plans - newser.com
Published on: 2025-10-29 21:31:53 - newser.com
How Sagimet Biosciences Inc. stock performs in interest rate cyclesEarnings Overview Report & Fast Gaining Stock Strategy Reports - newser.com
Will Sagimet Biosciences Inc. stock maintain dividend yieldJuly 2025 Selloffs & Capital Protection Trade Alerts - fcp.pa.gov.br
Reversal indicators forming on Sagimet Biosciences Inc. stockJuly 2025 Selloffs & Accurate Technical Buy Alerts - newser.com
Published on: 2025-10-28 04:41:46 - newser.com
Published on: 2025-10-28 00:51:25 - newser.com
Finanzdaten der Sagimet Biosciences Inc-Aktie (SGMT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sagimet Biosciences Inc-Aktie (SGMT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Martins Eduardo Bruno | Chief Medical Officer |
Jul 21 '25 |
Sale |
9.13 |
8,277 |
75,607 |
106,936 |
| Rozek Elizabeth | General Counsel and CCO |
Jul 21 '25 |
Sale |
9.13 |
10,780 |
98,471 |
183,726 |
0.70%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):